Company Overview
Prosolia, Inc. was established in 2003 to commercialize technology
arising from the laboratory of Dr. Graham Cooks, Aston Laboratories
of Mass Spectrometry at Purdue University, West Lafayette, Indiana.
Dr. Cooks and his research team have been innovators in the field
of Mass Spectrometry for many years and in recent years have made
a series of inventions while working on projects financially supported
by The Indiana Proteomics Consortium (‘dba Inproteo”).
Inproteo was established in 2001 by Eli Lilly, Indiana University,
and Purdue University in order to commercialize technologies, resident
within these institutions, which were deemed to be capable of satisfying
unmet needs in the mass spectrometer marketplace, but which required
additional focus in order for them to reach their full commercial
potential.
Prosolia’s mission is to develop and market revolutionary analytical
and preparative chemistry tools that will enhance and expand the
use of mass spectrometers.
Prosolia’s technology will lead to the commercialization of a series
of revolutionary analytical and preparative tools that will greatly
expand the utility of mass spectrometers beyond their current limitations.
This will be the case generally across the mass spectrometer market
through the introduction of the Omni Spray™ ion sources, and especially
in the pharmaceutical and proteomics markets, through the introduction
of the ESSI sources and the preparative mass spectrometers with
ion soft-landing.
Prosolia’s products will transform the way mass spectrometers are
used, the way biological research and testing is conducted, and
will also change the research community’s expectations regarding
the purity attainable for bio-polymeric materials.
Indeed, Prosolia’s mass spectrometer enhancements will “unlock
the power of mass spectrometry”, allowing procedures to be routinely
performed, which heretofore were very difficult if not impossible.
|